LENZ Therapeutics, Inc. Overview
LENZ market data
Business OverviewA provider-written description of this company or fund, with its source and observation date.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.
- Source
- massive
- Observed
- Cadence
- Reference data reviewed periodically
- Status
- fresh
Price HistoryDaily closing prices from recorded market data. The latest point represents the most recent completed daily period; prices can move before the next point appears.
LENZ price chart · 1M
- O
- 3.35
- H
- 3.38
- L
- 3.00
- C
- 3.01
- Vol
- 29,353.00
Daily history from Jun 25, 2021
- Source
- US equities market feed
- Observed
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & PerformanceOpen, range, return and notional-volume facts calculated from daily market bars.
- Open
- $3.35
- Previous Close
- $3.46
- Day High
- $3.38
- Day Low
- $3.00
- 52 Week High
- $32.08
- 52 Week Low
- $2.80
- 7 Day Return
- -13.51%
- 30 Day Return
- -20.79%
- 90 Day Return
- -43.95%
- 1 Year Return
- -85.97%
- Daily Notional Volume
- $88.4K Latest daily bar volume multiplied by its closing price.
Valuation & ProfitabilityProvider-backed valuation, profitability, and range metrics for the selected company. Display-only; never feeds scores or decisions.
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$2.85 Diluted earnings per share over the trailing twelve months.
- Beta
- 2.20 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -586.7% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $2.80 – $32.13 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $110M · P/B 1.76 · P/S 5.12.
Company NewsRecent source-attributed headlines linked to this symbol. Repeated headlines and low-signal items are filtered. Open a headline for its source and context.
10 captured
8-K filing — LENZ Therapeutics, Inc. (LENZ)SEC EDGAR ·